Evidence map›Paper›PMID 42613565›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Methods for the Evasion of Restriction-Modification Systems During Genetic Engineering of Fusobacterium Species.

Martha A Zepeda-Rivera, Elsa F McMahon, Kaitlyn N Lewis, Rutika Gavate, Falk Ponath, Christopher D Johnston

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martha A Zepeda-RiveraVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Elsa F McMahonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Kaitlyn N LewisGenomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Rutika GavateGenomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Falk PonathDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Christopher D JohnstonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. cdjohnston@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic manipulation of clinical Fusobacterium isolates is severely limited by strain-specific restriction-modification (RM) systems that recognize and degrade foreign DNA. This chapter describes strategies to evade RM defenses and improve transformation efficiencies across diverse Fusobacterium lineages. We employ a sequence-based "RM-silencing" method: in silico removal of nonessential regions and introduction of synonymous or GC-preserving nucleotide substitutions to disrupt RM recognition sites within coding and noncoding regions, respectively. Detailed protocols for high-molecular-weight genomic DNA isolation, computational motif identification, plasmid optimization, anaerobic preparation of electrocompetent cells, and optimized electroporation parameters are provided. Application of these methods has enabled successful delivery of replicative plasmids, linear recombination templates, and transposon cassettes into previously intractable Fusobacterium clinical isolates. Collectively, these techniques constitute a versatile toolkit to overcome RM barriers and advance functional genetic studies in Fusobacterium species.

Indexed as

DNA Restriction-Modification EnzymesFusobacteriumGenetic EngineeringDNA, BacterialElectroporationPlasmidsTransformation, BacterialDNA, BacterialDNA Restriction-Modification EnzymesElectroporationFusobacteriumGenetic engineeringRestriction-modification systemsSyngenicDNATransformation

Identifiers

PMID42613565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.